Actualizado 26/06/2008 11:06
- Comunicado -

Bowel Cancer Patients Live Longer Taking Xeloda (y 2)

For further information please contact: Julia Pipe, International Communications Manager - Xeloda, F.Hoffmann-La Roche, Mob: +41-79-263-9715, Email: julia.pipe@roche.com; Aba Edwards-Idun, OgilvyHealthPR, Mob : +44-7790-038579, Email : aba.edwards-idun@ohpr.com

Contenido patrocinado